Cardiovascular highlights from non-cardiology journals

O'Flaherty, Martin; Huffman, Mark D.; Capewell, Simon
September 2015
Heart;Sep2015, Vol. 101 Issue 17, p1433
Academic Journal
The article focuses on a study on decreasing mortality rates of acute myocardial infarction (AMI) and coronary heart disease (CHD). Topics discussed include a decrease in mortality rates shown by multinational monitoring of trends and determinants in cardiovascular disease (MONICA) project conducted by World Health Organization (WHO), focus of MONICA methodology on AMI and, low mortality rates with improved risk factors through evidence-based treatments for CHD.


Related Articles

  • Endarterectomy for diffuse right coronary artery disease. Yetkin, Ufuk; Goktogan, Tayfun; Ozpak, Berkan; Gurbuz, Ali // Internet Journal of Thoracic & Cardiovascular Surgery;2009, Vol. 14 Issue 1, p5 

    Coronary endarterectomy has become a safe procedure.In this study, we report a case that we applied a successful endarterectomy for diffuse right coronary artery disease.

  • Adjunctive treatment with eplerenone reduced 30 day all cause mortality in acute myocardial infarction. Pitt, B.; White, H.; Nicolau, J. // Evidence Based Medicine;Feb2006, Vol. 11 Issue 1, p14 

    The article reports on a study to determine whether adjunctive treatment with eplerenone can decrease morbidity and mortality better than placebo in patients with acute myocardial infarction (AMI) with left ventricular systolic dysfunction (LVSD) and heart failure. A randomized placebo...

  • FDA Actions: New Oral Antiplatelet Agent.  // Travel Medicine Advisor;Sep2009 Supplement, p1 

    The article announces the approval by the U.S. Food and Drug Aministration (FDA) of the use of prasugrel, a new oral anti platelet agent indicated for patients with acute coronary syndrome who are to be managed by angioplasty. The approval was based on a head-to-head study with clopidogrel that...

  • FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease. Logerqvist, B.; Diderholm, E.; Lindahl, B.; Husted, S.; Kontny, F.; Ståhle, E.; Swahn, E.; Venge, P.; Siegbahn, A.; Wallentin, L. // Heart;Aug2005, Vol. 91 Issue 8, p1047 

    Objective: To develop a scoring system for risk stratification and evaluation of the effect of an early invasive strategy for treatment of unstable coronary artery disease (CAD). Design: Retrospective analysis of a randomised study (FRISC II; fast revascularisation in instability in coronary...

  • Rescue Coronary Angiography after Failed Thrombolysis: A Real-Life Experience. Di Segni, E.; Agranat, O.; Zahav, Y. Har; Freimark, D.; Kaplinsky, E.; Hod, H.; Gruberg, L. // Cardiology;1998, Vol. 90 Issue 1, p48 

    Failed thrombolysis in acute myocardial infarction (AMI) patients is associated with a high risk of morbidity and mortality. Rescue or salvage percutaneous transluminal coronary angioplasty (PTCA) in this group of patients is still controversial. We report our experience with early emergency...

  • Percutaneous Coronary Intervention, Comorbidities, and Mortality among Emergency Department–Admitted ST-Elevation Myocardial Infarction Patients in Florida. Pathak, Elizabeth Barnett; Strom, Joel A. // Journal of Interventional Cardiology;Jun2010, Vol. 23 Issue 3, p205 

    Background: Risk of mortality following an ST-elevation myocardial infarction (STEMI) can be significantly reduced by prompt percutaneous coronary intervention (PCI). National guidelines specify primary PCI as the preferred recommended treatment for STEMI. In this study, we examined same-day PCI...

  • Lack of Benefit From Nitric Oxide Synthase Inhibition in Patients With Cardiogenic Shock. Ndrepepa, Gjin; Schömig, Albert; Kastrati, Adnan // JAMA: Journal of the American Medical Association;4/18/2007, Vol. 297 Issue 15, p1711 

    The article presents an editorial that discusses a lack of benefit associated with the inhibition of nitric oxide synthase in patients with cardiogenic shock complicating acute myocardial infarction (MI). The results of a randomized controlled study, called the Tilarginine Acetate Injection in a...

  • CARDIOVASCULAR AND CORONARY RISK ESTIMATION IN HYPERTENSION MANAGEMENT. Wallis, Erica J.; Ramsay, Lawrence E.; Jackson, Peter R. // Heart;Sep2002, Vol. 88 Issue 3, p306 

    Explores the principle and practice of using absolute cardiovascular disease or coronary heart disease risk for decisions on antihypertensive treatment. Importance of absolute risk in hypertension; Possible harm from treating low risk patients; Accuracy of Framingham risk estimates; Additional...

  • Commentary. Moyer, Carey D.; Berger, Peter B. // Evidence Based Medicine;Feb2006, Vol. 11 Issue 1, p14 

    The article comments on a study by B. Pitt and colleagues to determine whether adjunctive treatment with eplerenone can decrease morbidity and mortality better than placebo in patients with acute myocardial infarction (AMI) with left ventricular systolic dysfunction (LVSD) and heart failure. The...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics